205 related articles for article (PubMed ID: 21088767)
1. Synchrotron FTIR analysis of drug treated ovarian A2780 cells: an ability to differentiate cell response to different drugs?
Flower KR; Khalifa I; Bassan P; Démoulin D; Jackson E; Lockyer NP; McGown AT; Miles P; Vaccari L; Gardner P
Analyst; 2011 Feb; 136(3):498-507. PubMed ID: 21088767
[TBL] [Abstract][Full Text] [Related]
2. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
3. Highlighting a need to distinguish cell cycle signatures from cellular responses to chemotherapeutics in SR-FTIR spectroscopy.
Hughes C; Brown MD; Ball FJ; Monjardez G; Clarke NW; Flower KR; Gardner P
Analyst; 2012 Dec; 137(24):5736-42. PubMed ID: 23095763
[TBL] [Abstract][Full Text] [Related]
4. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines.
Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D
Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic signatures of single, isolated cancer cell nuclei using synchrotron infrared microscopy.
Pijanka JK; Kohler A; Yang Y; Dumas P; Chio-Srichan S; Manfait M; Sockalingum GD; Sulé-Suso J
Analyst; 2009 Jun; 134(6):1176-81. PubMed ID: 19475145
[TBL] [Abstract][Full Text] [Related]
6. The FTIR spectrum of prostate cancer cells allows the classification of anticancer drugs according to their mode of action.
Derenne A; Gasper R; Goormaghtigh E
Analyst; 2011 Mar; 136(6):1134-41. PubMed ID: 21249250
[TBL] [Abstract][Full Text] [Related]
7. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
9. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
[TBL] [Abstract][Full Text] [Related]
10. FTIR spectral signature of anticancer drug effects on PC-3 cancer cells: is there any influence of the cell cycle?
Derenne A; Mignolet A; Goormaghtigh E
Analyst; 2013 Jul; 138(14):3998-4005. PubMed ID: 23598424
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
12. Tracking infrared signatures of drugs in cancer cells by Fourier transform microspectroscopy.
Bellisola G; Della Peruta M; Vezzalini M; Moratti E; Vaccari L; Birarda G; Piccinini M; Cinque G; Sorio C
Analyst; 2010 Dec; 135(12):3077-86. PubMed ID: 20931110
[TBL] [Abstract][Full Text] [Related]
13. Effects of the confluence rate on the FTIR spectrum of PC-3 prostate cancer cells in culture.
Gasper R; Goormaghtigh E
Analyst; 2010 Dec; 135(12):3048-51. PubMed ID: 20871930
[TBL] [Abstract][Full Text] [Related]
14. Synchrotron Fourier transform infrared (FTIR) analysis of single living cells progressing through the cell cycle.
Whelan DR; Bambery KR; Puskar L; McNaughton D; Wood BR
Analyst; 2013 Jul; 138(14):3891-9. PubMed ID: 23762893
[TBL] [Abstract][Full Text] [Related]
15. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
16. Effect of lung resistance-related protein on the resistance to cisplatin in human ovarian cancer cell lines.
Wang W; Ke S; Chen G; Gao Q; Wu S; Wang S; Zhou J; Yang X; Lu Y; Ma D
Oncol Rep; 2004 Dec; 12(6):1365-70. PubMed ID: 15547764
[TBL] [Abstract][Full Text] [Related]
17. Increased optical pathlength through aqueous media for the infrared microanalysis of live cells.
Doherty J; Zhang Z; Wehbe K; Cinque G; Gardner P; Denbigh J
Anal Bioanal Chem; 2018 Sep; 410(23):5779-5789. PubMed ID: 29968104
[TBL] [Abstract][Full Text] [Related]
18. Cellular injury evidenced by impedance technology and infrared microspectroscopy.
le Roux K; Prinsloo LC; Meyer D
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Mar; 138():321-30. PubMed ID: 25506649
[TBL] [Abstract][Full Text] [Related]
19. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
